Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
DEY, L. P. et al v. TEVA PARENTERAL MEDICINES, INC. et al
Case Number:
1:09-cv-00087
Court:
Nature of Suit:
Judge:
District Judge Irene M. Keeley
Firms
Companies
Sectors & Industries:
-
March 24, 2014
Teva's Planned Generic Infringes Mylan Patents, Judge Says
A West Virginia federal judge ruled Friday that claims asserted by Mylan Inc. in a patent-infringement suit over Teva Pharmaceutical USA Inc.'s planned generic version of Mylan's respiratory illness drug Perforomist weren't invalid due to anticipation, obviousness or enablement.
-
July 17, 2013
Teva Drug Would Infringe Mylan Patent, Judge Says
A West Virginia federal judge ruled Wednesday that an treatment proposed by generic drugmaker Teva Pharmaceutical USA Inc. would violate a patent covering Mylan Inc.'s respiratory illness drug Perforomist.